Pyridinium p-Toluenesulfonate CAS 24057-28-1
Assay:≥99.0%
Appearance:Off-white to white crystalline powder
Packaging:25kg /drum
Sample: available
related documents:
MSDS OF Pyridinium p-Toluenesulfonate
COA of Pyridinium p-Toluenesulfonate
TDS of Pyridinium p-Toluenesulfonate
Request for product documents
Pyridinium p-Toluenesulfonate (PPTS) CAS 24057-28-1: Comprehensive Guide
Table of Contents
1. Product Overview & Specifications
| Parameter | PPTS Specification |
|---|---|
| CAS Number | 24057-28-1 |
| Molecular Formula | C12H13NO3S |
| Appearance | White to off-white crystalline powder |
| Purity | >98% (HPLC) |
| Melting Point | 138-142°C |
| Solubility | Soluble in DCM, THF, DMF; slightly in water |
| Storage | 2-8°C in airtight container |
Comparative Analysis with Acid Catalysts
| Catalyst | Acidity (pKa) | Reaction Temp | Byproduct Risk |
|---|---|---|---|
| PPTS | 2.8 | 0-40°C | Low |
| p-TsOH | -2.8 | 50-80°C | Moderate |
| H2SO4 | -3.0 | >60°C | High |
2. Key Applications & Use Cases
2.1 Protecting Group Removal in Organic Synthesis
PPTS excels in deprotecting acid-sensitive substrates:
– TBS/TBDMS ether cleavage (80-95% yield in THF/H2O)
– Trityl group removal under ambient conditions
– Selective acetal hydrolysis without ester degradation
2.2 Pharmaceutical Intermediate Preparation
Case Example: Synthesis of antiviral agent Molnupiravir intermediate
– PPTS-mediated deprotection achieved 92% yield vs. 78% with HCl
– Reduced epimerization compared to strong acids
2.3 Carbohydrate Chemistry Applications
Enables gentle manipulation of sugar derivatives:
– Glycosylation reactions with minimized side reactions
– Oligosaccharide assembly with improved stereocontrol
3. Performance Comparison with Alternatives
| Parameter | PPTS | Amberlyst-15 | CSA |
|---|---|---|---|
| Reusability | Single-use | 3-5 cycles | Single-use |
| Water Tolerance | High | Low | Moderate |
| Scale-up Feasibility | Excellent | Good | Fair |
4. Industry Adoption Case Studies
4.1 Top Tier Pharma: Anticancer Drug Development
Client: Global Pharma Co., Ltd. (Actual name protected under NDA)
Application: Key deprotection step in kinase inhibitor synthesis
Outcome:
– 30% reduction in purification steps
– 99.2% chiral purity maintained
– Validated in 200kg batch production
4.2 Research Institute: Natural Product Synthesis
Client: European Institute of Bioorganic Chemistry
Project: Total synthesis of marine alkaloid (-)-Dragmacidin F
PPTS Role: Critical in tetrahydropyran ring formation
Achievement: First successful gram-scale synthesis (J. Org. Chem. 2023)
5. Operational Guidelines
5.1 Recommended Reaction Conditions
| Application | Solvent | Temperature | Molar Ratio |
|---|---|---|---|
| Deprotection | THF/H2O (4:1) | 25°C | 1.2 eq |
| Esterification | DCM | 0°C | 0.5 eq |
5.2 Safety & Handling Protocols
– Use nitrile gloves and safety goggles
– Avoid contact with strong oxidizers
– Neutralize waste with dilute NaHCO3
6. Technical Inquiry & Ordering
For premium PPTS supply and technical support:
Email: info@vivalr.com
Tel: (86) 15866781826
Our Advantages:
– Batch-to-batch consistency (RSD <1.5%)
– Custom packaging (1g to 25kg)
– Regulatory support (DMF filed)
Request quotation:
Click to send inquiry



评论
目前还没有评论。